comparemela.com

Latest Breaking News On - Chief innovation officer ryan keeling - Page 1 : comparemela.com

Diaceutics Backs 2023 Views Despite First-Half Widened Loss; CEO Steps Down

By Michael Susin Diaceutics reported a widened pretax loss for the first half of 2023, driven by higher costs despite a revenue jump, but backed its.

Michael susinRyan keelingPeter keelingChief executive peter keelingChief innovation officer ryan keelingArticle normalHealthcare life sciencesHealthcare support servicesDiagnostic medical research servicesFinancial performanceManagement movesCorporate industrial newsSenior level managementContent typesFactiva filtersC amp ampe executive news filter

Diaceutics revenue grows but loss widens, CEO Keeling to step down

Diaceutics PLC on Tuesday reported strong revenue growth in its first half despite a widened loss, as well as strong demand from new customers despite a cautious atmosphere in the pharmaceutical.

Emma curzonPeter keelingRyan keelingDeborah davisAlliance news ltdAlliance newsChief executive officer peterChief innovation officer ryan keelingChair deborahAll rights

vimarsana © 2020. All Rights Reserved.